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Abstract
Background: In this study, we present a SVM-based ranking algorithm for the concurrent learning of compounds
with different activity profiles and their varying prioritization. To this end, a specific labeling of each compound was
elaborated in order to infer virtual screening models against multiple targets. We compared the method with several
state-of-the-art SVM classification techniques that are capable of inferring multi-target screening models on three
chemical data sets (cytochrome P450s, dehydrogenases, and a trypsin-like protease data set) containing three
different biological targets each.
Results: The experiments show that ranking-based algorithms show an increased performance for single- and
multi-target virtual screening. Moreover, compounds that do not completely fulfill the desired activity profile are still
ranked higher than decoys or compounds with an entirely undesired profile, compared to other multi-target SVM
methods.
Conclusions: SVM-based ranking methods constitute a valuable approach for virtual screening in multi-target drug
design. The utilization of such methods is most helpful when dealing with compounds with various activity profiles
and the finding of many ligands with an already perfectly matching activity profile is not to be expected.
Keywords: Machine learning; Support vector machine; Ranking; Virtual screening; Multi-target
Background
Considering the large potential market for drugs in some
areas, like the treatment of CNS disorders [1], accompa-
nied by a vast increase in R&D funding over the last years
[2], one could argue that the struggle for new drugs should
be crowned with success. However, the pharmaceutical
industry yielded fewer therapeutic agents in relation to
their expenses [2]. The confidence that drugs for sin-
gle targets are capable of curing complex diseases, like
cancer or diabetes, is deemed to be the cause of the
aforementioned decrease in output [3,4]. The prevailing
paradigm in rational drug design in the last decades could
be described by the creation of selective ligands that are
tailored to one target. Dealing with one target only helps
to reduce side effects [5-7]. Albeit, the effectiveness of a
drug is not only dependent on how well it can inhibit or
activate its biological target. It is also a matter of how
robust its underlying system is against perturbations [3].
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In retrospective, selective high-affinity binders are an
ideal case. In reality ligands effecting more than one
target simultaneously are more likely to occur [8]. Espe-
cially when dealing with complex diseases, single-target
drugs seem to be the wrong approach since the inhibi-
tion of individual proteins can be counteracted by addi-
tional signaling routes [5,7,9] and cross-talk [10,11], or
the influence of therapeutic agents is compensated [3,12].
Based on the complex pharmacology of drugs against
AIDS, cancer, metabolic and CNS disorders, selectively
non-selective drugs tend to be more effective than a sin-
gle high-affinity binder [1] because multiple associated
processes have to be considered [13,14].
In recent decades multi-target drugs were more likely to
be discovered by serendipitous events rather than know-
ing their promiscuity beforehand [7]. However, combining
computational methods with the increasing amount of
available bioactivity information should also yield com-
pounds that express a certain activity profile with a
higher likeliness [15]. According to Morphy et al. [6], it
is unlikely to find a ligand during screening that already
has all desired properties. Hence, there exist mainly three
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scenarios for the design of a multi-target drug: a) Two
ligands that bind with a high affinity to distinct targets are
used to “design in” a new ligand by uniting their structural
elements responsible for activity. b) It is possible to iden-
tify a ligand that already shows a weak activity against the
desired activity profile. In this case, the ligand has to be
modified in order to increase its affinity. c) A multi-target
ligand can also show an activity against an undesired tar-
get. Thus, a medicinal chemist has to “design out” the
adverse binding properties [6]. Hence, one cannot rely on
the identification of already perfect multi-target ligands
during high-throughput screening. Instead it can be con-
sidered as beneficial to screen for molecules that partially
fulfill the desired profile. These suboptimal ligands can
then be built on to design a ligand with the appropriate
activity profile.
The concept of multi-target drug design has multiple
benefits compared to a drug cocktail made of various lig-
ands or a multicomponent drug. When several molecules
enter the human body the ADMET characteristics of each
ligand have to be taken into account. Albeit, a multi-target
drug accounts only for the absorption and elimination
of a single molecule, which is a more manageable task
[16]. Furthermore, a multi-target drug usually binds with
a lower affinity to each of its targets in comparison to a
single target drug [17], since the same key has to fit into
multiple locks. Without the requisition of high-affinity
binding, the process of multi-target drug design is not
subject to the same high constraints as single-target drug
design and therefore a higher amount of proteins can be
targeted [13].
High-throughput screens (HTSs) are a valuable data
source to infer predictive structure-activity relationships
for virtual screening [18]. Standard machine learning
methods such as Bayesian learning [19], neural networks
[20], and support vector machines [21] (SVMs) are able to
train virtual screening models on high-throughput data.
The models can support the drug design process by facil-
itating the prediction of the sensitivity of a compound
against a specific target. However, in multi-target drug
design a lead candidate should have a desired sensitivity
profile against a number of targets. If HTSs against addi-
tional targets based on the same combinatorial library are
available, a machine learning method can take advantage
of this data to include multiple sensitivity information in
the virtual screening model. Ma et al. [22] combined sep-
arate sensitivity models for each of the targets to screen
a database for compounds with a desired multiple-target
profile (see Figure 1c). Their approach combined the pre-
diction of separate sensitivitymodels to estimate the selec-
tivity profile of a compound. However, separate models
for individual targets are evaluated. Recently, large margin
ranking SVMs [23] and structural SVMs [24] were intro-
duced as valuable methods for virtual screening. Using a
specific encoding, rankingmethods can be applied to infer
a model for a certain activity profile of compounds for dif-
ferent biological targets. In a study of Wassermann et al.
[25] a ranking SVM was used for a SVM-based search-
ing of target-selective compounds in order to discrimi-
nate between non-selectively active, selectively active, and
inactive compounds for data sets with two targets.
The aim of this study is to present a machine learn-
ing framework based on large margin ranking methods,
which is able to infer a model of target specific sensitiv-
ity information from HTSs against multiple targets. The
method can be divided into two parts. First, we suggest
a way to incorporate the data of HTSs against multiple
targets into a single encoding. The resulting encoding
represents the activity profile of a compound against a
specific selection of targets and can efficiently be learned
by the aforementioned ranking methods. Thus, in the
second step, we employ a modified version of the linear
ranking SVM SVMRank [26] to learn the encoding in a sin-
gle machine learning model. We evaluated our method on
a cytochrome P450 data set, and a dehydrogenase data set,
both containing compounds with different activity pro-
files against three targets. Then we compared our results
with a recent study of Heikamp et al. [27] about the lin-
ear combination of individual SVMmodels and the results
of a multi-class SVM. At the end, we also evaluated the
robustness of our method with respect to different activity
cutoffs on a trypsin-like protease data set.
The results show that our method is able to infer
machine learning models that incorporate sensitivity
information from HTSs against multiple targets. In addi-
tion, compounds that do not completely match a respec-
tive activity profile are still ranked higher than entirely
undesired profiles or mere decoys. To conclude, we think
that the elaborated machine learning framework is a valu-
able tool to buildmodels for screening compound libraries
for molecules with a desired sensitivity profile and com-
pounds with an almost matching activity profiles. Con-
sequently, molecules that only partially fulfill the desired
profile can then be modified by a medicinal chemist to
comply with the given requirements.
Methods
In this section we describe the linear combination of indi-
vidual SVM models and the concept of the multi-class
SVM (MC-SVM). Afterwards, we present the modified
linear ranking SVM, which is able to learn various activ-
ity profiles. An overview of the methods is illustrated in
Figure 1. Finally, we introduce the encoding that incorpo-
rates information from HTSs against multiple targets.
Linear combinations
The concept of the linear combination of SVM mod-
els was introduced by Geppert et al. [28] and applied in
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Figure 1 Overview of the workflow of different methods for multi-target screening. The example assumes a data set with a main target T1
and a secondary target T2 which should be avoided by the ligand. SVMRank (a) and the multi-class SVM (b) learn the encoding s of the activity
profile. Separate SVM models (c) predict the activity of i via act(i) and infer distinct classes based on the proposed encoding. The SVM with linear
combinations (d) uses subsets of the data set to build several models that are combined before prediction. The encoding s of the desired activity
profile is reflected in the factors c of the linear combinations.
a recent study of Heikamp et al. [27] to the prediction
of active molecules with respect to overlapping activity
profiles against multiple targets. This approach is based
on a combination of the weight vectors w of separate
SVM models to a single united weight vector wcombined .
Equation 1 shows the linear combination of n weight vec-
tors, where wi is the weight vector of the i-th model and






The linear factor ci of each model can attain a posi-
tive value to favor models representing desired proper-
ties or negative values to exclude undesired properties.
Hence, the new model unites in its combined weight vec-
tor the facilitation of desired properties and strengthens
the downgrading of undesired properties. To this extent
the linear combination of SVM models is capable to rank
compounds with overlapping activity profiles of tn targets
in a way that compounds with a certain profile receive a
better rank than compounds that do not match a specific
profile. An individual weight vector wi is generated for
each target ti with known active compounds and decoys.
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Figure 2 Support vector classification (SVC). Illustration of an SVC
classification function represented bywTx. The slack variables
ξi = yiwTx facilitate the trade-off between the size of the margin
(indicated by a gray tube) and the error due to misclassifications.w
denotes the weight vector, yi the label of instance i, and x is the
feature vector. ξi can assume a positive value between 0 and for 1 for
training instances located in the margin. For instances on the wrong
side of the margin ξi is less than 0. Support vectors are indicated by a
red ring.
Then, using a linear factor ci for each weight vector, com-
pounds can be ranked according to a desired activity
profile (see Figure 1d). We employed the linear SVM of
the LIBLINEAR library [29] for the implementation of this
method.
Multi-class SVM
Multi-class SVMs (MC-SVMs) are also able to learn the
encoding of the different activity profiles by interpreting
every possible rank score s as a separate class. As shown
in Figure 1b, the class of an unknown compound xi is then
predicted by f (xi) = argmaxkwTk xi. Hence, MC-SVMs
are able to include sensitivity information. However, MC-
SVMs process no information about the rank order of
the different classes. For example, swapping an inactive
compound with an active, sensitive compound induces
the same overall error as swapping a sensitive compound
with a compound expressing an undesired activity profile.
Additionally, in contrast to ranking algorithms, the out-
put of a MC-SVM is the predicted class and not a gradual
ordering.
We employed the linear MC-SVM of the LIBLINEAR
library [29]. The implementation is based on the MC-
SVM formulation of Crammer and Singer [30]. Unlike one
versus all or all versus all strategies with binary classifiers,
their formulation trains a multi-class SVM model based
on a single optimization problem.
Linear ranking SVM
Large margin ranking methods are valuable tools for solv-
ing information retrieval tasks such as virtual screening.
With a suitable encoding, data sets with compounds of
various activity profiles can labeled in a way that a ranking
method can learn the different importance between them.
Hence, we employed the linear ranking SVM SVMRank
with a modified loss function to train the sensitivity
encoding described in this paper.
SVMRank is based on the same structured SVM frame-
work used by the virtual screening approach StructRank
[24]. The main difference between both ranking meth-
ods is that SVMRank takes into account all ranks, whereas
StructRank focuses on the topmost ranks. Thus, SVMRank
optimizes the overall ranking performance (see Figure 3).
SVMRank learns a linear ranking function f (x) = wTx.
The weight vector w = (w1, . . . ,wn) is optimized such
that f (x) is a large-margin function that minimizes the
number of swapped ranks. The standard error function
optimized by SVMRank is the fraction of miss-ranked pairs
defined in Equation 2.




loss(i, j) = I{f (xi)−f (xj)<0} +
1
2 I{f (xi)−f (xj)=0} (3)
P = {(i, j)|si > sj} (4)
Iφ is an indicator variable which takes the value one if
the predicate φ is true and zero otherwise. P is the set of
Figure 3 Ranking SVM. The learning algorithm of the ranking SVM
yields a weight vectorw that minimizes the pairwise loss dependent
on the margin when the training instances are projected ontow. The
overall ranking error is reduced to approximate the given ordering in
the training set as effectively as possible alongw. The principle of
margin re-scaling allows for a ranking dependent on the degree of
discrepancy in the ranking order and the pairwise loss is influenced
by the k-partite ranking error. Therefore, ranking score 2 higher than
score 4 is punished with a greater loss than a wrong order of the
scores 4 and 3. This is indicated with an increasing margin dependent
on the respective scores that are compared with each other.
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pairs that could be swapped. Loss(i, j) calculates the error
if a pair (i, j) is miss-ranked by the ranking function f (x).
I{f (xi)−f (xj)=0} represents the case where two compounds
with different ranks are assigned the same function value
f (x). If the compounds are sorted by f (x), then an error
occurs with a probability of 0.5. The ranking error func-
tion of Equation 2 has the disadvantage that it does not
consider the difference between two scores si and sj. Thus,
the original SVMRank cannot take into account and opti-
mize the model for the different importance of the rank
scores. To tackle this undesired behavior we used the k-
partite ranking error (Equation 5) as error function for
optimization.












Clearly, Equation 5 includes the margin between the
scores si and sj and, thus, the different importance of the
rank scores. The adjusted loss function can be readily inte-
grated into the optimization problem solved by SVMRank.
The time complexity of the original SVMRank formulation
isO(d · l+R · l+ l · log(l)), where l is the number of training
instances, d is the average number of non-zero features in
the input vectors xi and R is the total number of different
scores si [26]. Including the k-partite ranking error in the
linear ranking model requires an additional loop over the
total number of different scores R. This additional loop
results in a time complexity ofO(d · l + R2 · l + l · log(l)).
Hence, the algorithm is scalable to large chemical data
sets depending on the average number of non-zero fea-
tures d and number R of different rank scores si. Both R
and d should be kept as small as possible. Consequently,
the number of targets is a limiting factor. Additionally,
the molecular encoding used to encode the molecules
should result in a sparse feature vector to reduce the
dimensionality d.
The real-valued prediction of the linear ranking func-
tion f (x) allows a gradual ranking of all test compounds,
which is a huge advantage compared to methods that only
output class or rank values. A further advantage lies in the
linearity of the ranking function f (x) . The weights w of
this function can potentially be interpreted and visualized
in the same way as for linear SVMs. Therefore, it should
be possible to represent the influence of each feature on
the ranking order.
A feature with a high positive weight can be regarded as
desired feature with respect to the provided rank scores,
and compounds with such features are more likely to be
ranked higher than other compounds. A negative weight
implies undesired or unimportant properties at the lower
end of the ranking. The recognition of the substructures
related to a high rank is facilitated by representing the
weight of each feature with a color code, as it was pro-
posed by Rosenbaum et al. [31]. However, a feature with a
high weight only corresponds to a high rank and not to a
certain activity against a specific target.
Encoding sensitivity for multiple targets
In this section we propose an example encoding for a
hypothetical data set with three targets T1, T2, and T3
for a single- and dual-target activity profile. The chemical
data sets used in this study are labeled on the basis of the
described encoding.
A virtual screening against m multiple targets can
be represented as a set D of l labeled fingerprints of
compounds (xi, yi1, · · · , yik , · · · , yim), i = 1, · · · , l, k =
1, · · · ,m, xi ∈ Rn, yik ∈ {0, 1}. Each compound i has a
label yik for every target k. The label can be either inactive
(yik = 0) or active (yik = 1). The goal to obtain sensitive
lead candidates should be reflected by an encoding that
incorporates information from HTSs against multiple tar-
gets. Hence, the target specific labels of a compound are
encoded into a single label that can be utilized by a rank-
ing method as the rank scores si. The main idea of our
encoding is to ensure sensitivity for a main activity pro-
file while penalizing deviations from the desired activity
profile. Consequently, compounds with almost matching
activity profiles receive a high score whereas compounds
with less desirable profiles obtain lower scores. Decoys are
assigned the score zero.
In order to show that this approach is also valid for
single-target drug design, we started our experiments with
single-target activity. One target was regarded asmain tar-
get with the highest priority and other activity profiles
were labeled according to what extent they differ from the
desired activity profile. To be more precise, the encod-
ing of each compound reflects the number of labels yik
that have to be changed from 0 to 1 or vice versa, in
order to match the desired activity profile. Compounds
that are not active for the main target were regarded as
decoys regardless of their activity to the other targets. The
precise labeling for the single-target activity is shown in
Table 1. For the experiments assessing dual-target activ-
ity, the desired activity profile for two targets was regarded
as main target with the highest priority. Other activity
profiles were then labeled depending on how similar they
are to the desired activity profiles. Compounds that also
target the third undesired target were deprioritized (see
Table 2). It is also possible to assign a different prioriti-
zation to each of the targets, which results in a slightly
different ranking scheme. For single-target activity pro-
files, avoiding T2 could be more important than T3 (see
Table 3). When screening for compounds with dual-target
activity profiles for T1 and T2, getting compounds for
T1 could be considered more important than for T2 (see
Table 4).
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Table 1 Labels for a single-target T1
T1 T2 T3 Label
1 0 0 3
1 1 0 2
1 0 1 2
1 1 1 1
0 1 0 0
0 0 1 0
0 1 1 0
0 0 0 0
As main target, T1 receives the highest value for its label. Other activity profiles
are categorized on the basis of how strong they differ from the main activity
profile.
In the study of Wassermann et al. [25] selective com-
pounds were labeled with 1, decoys with 0, and non-
selective active compounds with −1 in order to remove
non-selective compounds for the higher ranks of a virtual
screening. This was done for data sets with two targets
each. In this study, decoys and compounds with com-
pletely undesired activity profile are assigned the label
with the lowest priority. We think this more is appro-
priate for multi-target vHTS since even fingerprints of
compounds that are non-selective still contain informa-
tion why this compound is considered active for a specific
target. Inactive compounds simply do not contain infor-
mation for activity at all. This approach should result in a
more precise ranking for multi-target vHTS and can also
screen for compounds with slightly deviating activity pro-
files for further optimization. However, this applies only
to well prepared data sets. If a data set contains highly
promiscuous compounds against a broad range of targets,
the features of such compounds rather interfere with the
model than add additional information. The similarity-
based methods described in this paper cannot distinguish
between compounds for the desired targets and highly
Table 2 Labels for a dual-target T1 and T2
T1 T2 T3 Label
1 1 0 3
1 0 0 2
0 1 0 2
1 1 1 1
1 0 1 0
0 0 1 0
0 1 1 0
0 0 0 0
The activity profile for the two main targets T1 and T2 receives the label with the
highest value. Other activity profiles are then categorized depending on to what
extent they fulfill the desired activity profiles. Compounds that also target T3 are
deprioritized.
Table 3 Labels for a single-target T1 with deprioritization
of T2
T1 T2 T3 Label
1 0 0 3
1 1 0 1
1 0 1 2
1 1 1 0
0 1 0 0
0 0 1 0
0 1 1 0
0 0 0 0
As main target, T1 receives the highest value for its label. As for other activity
profiles, avoiding T2 is more important than avoiding T3. Non-selective actives
are regarded as decoys.
promiscuous binders once a data set is assembled. In case
of doubt, such compounds should be discarded from the
data set.
Our multi-target ranking method will be referenced as
MT RANK and the ranking strategy of Wassermann et al.
[25] as S RANK. For the weights of the linear combina-
tions we always chose a linear factor of 2 for the desired
activity profile and −1 for the models of the undesired
targets to prioritize the main target(s).
From a machine learning perspective, the proposed
encoding results in a ranking or ordinal regression prob-
lem. However, the different prioritizations of activity pro-
files induce a difference in the importance of the ordinals
which is reflected by the margin between the possible
scores si. A machine learning algorithm trained on the
proposed encoding should be able to learn this difference
in importance.
Molecular encoding
The molecular fingerprints used in this study were gener-
ated with the Java library jCompoundMapper developed
Table 4 Labels for a dual-target T1 and T2 with
prioritization of T1
T1 T2 T3 Label
1 1 0 3
1 0 0 2
0 1 0 1
1 1 1 0
1 0 1 0
0 0 1 0
0 1 1 0
0 0 0 0
The activity profile for the two main targets T1 and T2 receives the label with the
highest value. As for other single-target activity profiles, T1 is more important
than T2. T3 has to be avoided. Non-selective actives are regarded as decoys.
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by Hinselmann et al. [21]. We chose the common circu-
lar topological extended-connectivity fingerprint (ECFP)
[32] to calculate the fingerprints for every compound in
test and training sets. The use of ECFPs allows a fast com-
parison of molecules in an automated fashion. On the
basis of the results of a previous paper from Rosenbaum
et al. [33] we chose a bond diameter of 6 and a hash
space of size 220 bits as additional preferences for the
hashed fingerprints. Further details can be found in the
documentation of jCompoundMapper [21]. We generated
functional-connectivity fingerprints (FCFP) with a bond
diameter of 6 with CDK [34,35] in order to examine if they
yield a similar performance. Detailed results of the FCFPs
are not shown in this paper.
LIBLINEAR and the linear ranking SVM use the dot
product kernel which generally increases the ranking
error or reduces the AUC, since the fingerprints of larger
molecules result in higher similarities. However, we nor-
malized each fingerprint on the basis of its length, such
that ‖xi‖ = 1. Consequently, an application of the dot
product kernel to these normalized fingerprints is equal
to the cosine kernel (see Equation 6). By this means
the dot product kernel is normalized to [0, 1] and thus
is not influenced by the size of the fingerprints, which
leads to better performance on chemical data sets in
general.







In this section we describe the chemical data sets and
their preparation. Then, we present the experimental
setup and parametrization of the algorithms used for the
experiments.
Chemical data
Based on the chemical data sets used in the study of
Heikamp et al. [27] the same compounds were down-
loaded from PubChem’s BioAssay database [36]. As a
result two data sets with compounds expressing single-,
dual-, and triple-target activities from confirmatory bioas-
says were generated. The first data set comprises com-
pounds with the aforementioned activity profiles for
three biological targets of the cytochrome P450 fam-
ily (CYP2C19, CYP2D6, and CYP3A4). The second data
set consists of inhibitors for the three dehydrogenases
aldehyde dehydrogenase 1 (ALDH1A1), hydroxyacyl-
coenzyme A dehydrogenase type II (HADH2), and 15-
hydroxy-prostaglandin dehydrogenase (HPGD). Figure 4
shows the composition of both data sets with respect
to their activity profiles. The data set representing the
cytochrome P450s contains 4807 compounds in total and
the dehydrogenases data set 44440 compounds in total.
To investigate the behavior (e. g., robustness) of the
described multi-target screening methods with respect to
different activity cutoffs in the same data set, a trypsin-
like protease data set was generated from BindingDB [37].
This data set comprises 881 compounds with pKi values
for Factor Xa (FXa), Thrombin (Thr), and Trypsin (Try).
The distribution of the pKi values is shown in Figure 5.
Based on the description in Additional file 1, an initial
activity cutoff of 6.1 was chosen. Since the pKi values for
FXa are more equally distributed than for Thr and Try,
FXa was chosen as the single main target for this data set.
In the same way the data set was processed for the activity
cutoffs 5.6 and 6.6. A compound was regarded as selective
for FXa, if both of the secondary targets have a pKi value
lower than the chosen cutoff.
To ensure an unbiased comparability of compounds in
the chemical data sets the Standardizer, JChem 5.12.0,



















1906 decoys 39355 decoys
Figure 4 Composition of the cytochrome P450 and dehydrogenase data sets. Both Venn diagrams show the composition of the active
compounds with respect to their activity profiles in the cytochrome P450 data set (left) and the dehydrogenase data set (right).
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Figure 5 Distribution of pKi values of the trypsin-like protease
data set. This figure shows the distribution of pKi values of the three
trypsin-like protease targets Factor Xa (FXa), Thrombin (Thr), and
Trypsin (Try). The initial activity cutoff is drawn as a vertical dashed
black line at 6.1.
used for each molecule in training and test set to canoni-
calize and transform every molecular structure. The stan-
dardization process was parameterized according to the
guidelines of Fourches et al. [39]. As a result, each molec-
ular structure was neutralized, tautomerized, aromatized,
provided with explicit hydrogens, and underwent a two
dimensional cleaning of its atom coordinates.
Experimental setup
Similar to the study of Heikamp et al. [27] two exper-
iments were carried out for the cytochrome P450 and
the dehydrogenase data sets. At first, the algorithms were
trained with a focus on compounds with a single-target
activity. Then, the focus was changed to compounds that
show dual-target activity profiles. The compounds of each
data set were subdivided according to their activity profile.
We sampled n compounds at random for training from
each subset, whereby n denotes half of the smallest subset
available for the same category (single, dual, and triple).
Thus, each subset was limited by the size of the subsets
from the same category. Each sampling was repeated 20
times. Compared to previous experiments with these data
sets, we sampled 1000 decoys for each training set since
linear SVMs allow for training an SVCmodel with a larger
amount of instances. Regarding the trypsin-like protease
data set, 20 training and test sets were sampled such that
the distribution of labels was the same within both sets.
The linear ranking SVM can distinguish different activ-
ity profiles via a specific labeling of the training instances.
Thus, compounds of each activity profile were included in
each training set of SVM RANK and MC-SVM. Regard-
ing the linear SVM with linear combinations (SVM
LC), only compounds with the respective activity pro-
file were used as active compounds in each training set
as it was done in the original study. Each test set con-
tained all remaining compounds that were not used for
training.
The standard linear SVM, the linear ranking SVM, and
the MC-SVM require the regularization parameter C for
training. To determine a feasible value for C, a grid search
with a 2-fold cross-validation was performed. Guided
by a study of Agarwal et al. [23] we chose the range
{0.1, 1, 10, 100, 1000} for the linear SVM as well as for the
MC-SVM. The range
{
10−6, 10−5, 10−4, 10−3, 10−2
}
was
selected for the linear ranking SVM. The specific labeling
for the ranking SVM andMC-SVMwas done according to
the desired activity profile. All methods and evaluations
were implemented in an in-house Java-based machine
learning library.
For each training set the corresponding test set was
labeled in two different ways to observe the performance
on a test set with only the desired activity profile and
on a test set with also deviating, yet workable activ-
ity profiles. At first, a binary labeling was used that
reflected the activity to the main target(s) only. The sec-
ond labeling met the same scheme that was used for the
training sets of the linear ranking SVM. To this extent,
the performance of the respective algorithms could be
observed when screening for a single desired activity pro-
file or when slightly deviating activity profiles are also
relevant.
Results and discussion
At first, we describe the validation of our experimental
setup with data sets used in a study of Agarwal et al.
[23]. Then, we present a comparison between the lin-
ear ranking SVM (RANK) and a standard linear SVM
without linear combinations (SVM) on a simple binary
labeling of training and test sets as baseline. Subsequently,
we show and discuss the results of the three approaches
MT RANK, SVM LC and MC-SVM on the chemical data
sets with different activity profiles for single-target and
dual-target activity with both a binary labeling and the
proposed encodings of the test sets. Then, the results of
the trypsin-like protease data set with different activity
cutoffs are presented. The MC-SVM was only applied to
the non-binary test sets, because it requires a multi-label
classification problem. The binary test sets were also used
to examine and compare the different ranking strategy of
Wassermann et al. [25] (S RANK) for single-target activity
profiles.
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Validation of the experimental setup
First, the performance of the linear ranking SVM was val-
idated with data sets used in a study of Agarwal et al. [23].
In this validation the linear ranking SVM and the linear
SVMwithout linear combinations were compared accord-
ing to their AUC performance on a binary labeling. The
given ranking error is equal to 1 − AUC. We selected the
five data sets CDK2, COX2, FXa, PDE5, and α1AAR pro-
vided by Jorissen et al. [40] with the four splits 1st/2nd,
2nd/1st, odd/even, and even/odd. We could observe that
15 out of 20 performance evaluations were in favor of the
linear ranking SVM. This reflects the tendency that SVM-
based ranking shows a better performance than SVM
classification in general. Therefore, the implementation of
the linear ranking SVM and the experimental setup can be
regarded as sound.
Comparison with standard linear SVM
The results of the baseline data sets are depicted in
Figures 6 and 7. As with all other data sets used in this
study 20 training and test sets were sampled at random
and the mean ranking error was calculated. The perfor-
mances of the different baseline data sets are consistent
with the results of Agarwal et al. [23] for a binary labeling
of training and test sets. The linear ranking SVM can com-
pete with the standard linear SVM and shows a slightly
better performance for some targets, especially on the
data sets for dual-target activity.
Single-target activity
Figure 8 shows the results of the training sets for
single-target activity with the setup from Table 1 and
a binary labeling of the test sets for the cytochrome
P450s and dehydrogenases. The results show an overall
better performance of the multi-target ranking method
(MT RANK) compared to SVM with linear combina-
tions (SVM LC). Furthermore, the higher ranking error of
the selectivity ranking (S RANK) shows that this method
has a negative influence on the recognition of single-
target ligands. This method was originally applied to
data sets with two targets only. A data sets with three
or more targets contains also more non-selective activ-
ity profiles. Therefore, grading non-selective molecules
lower than decoys can have an adverse effect. As said
before, even non-selective ligands still contain activity
information which can be utilized for a finely graduated
ranking.
Figure 9 presents the results of the experiments with
the same training sets as in Figure 8, but with the elab-
orated labeling from Table 1 applied to the test sets. In
this experiment the ranking error is not linked to the
AUC because of the non-binary labeling of the test sets.
Themulti-target rankingmethodMTRANK outperforms
SVM LC and the MC-SVM in each experiment. As to be
expected, the graded labeling of the compounds results
in a better ranking. The ranking method is able to learn
the different importance between various activity pro-
files. Thus, ligands with a partially desired activity profile
can be ranked higher than compounds with completely
undesired profile.
Single-target activity with different importance of
secondary targets.
In this section we show the results of the same experi-
ments with the single-target activity profiles but with the
alternative labeling from Table 3 applied to binary test
sets (see Figures 10 and 11) and ranking test sets (see
Figure 6 Performance of the cytochrome P450 and dehydrogenase baseline data sets for single-target activity. Each boxplot depicts the
mean ranking error on the 20 randomly generated test sets for each target. The given ranking error is equal to 1 − AUC.
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Figure 7 Performance of the cytochrome P450 and dehydrogenase baseline data sets for dual-target activity. Each boxplot depicts the
mean ranking error on the 20 randomly generated test sets for each target. The given ranking error is equal to 1 − AUC.
Figures 12 and 13). In this setup it was important to avoid
one of the two secondary targets with higher priority than
the other. The results show, that for the cytochrome P450
data set this ranking scheme is more beneficial regarding
a binary classification than the one described in Table 1.
Treating non-selective actives as decoys with a label of 0
seems to improve the ranking performance. The results
of the ranking test sets show, that avoiding one secondary
target with higher priority is more demanding for MT
RANK and MC-SVM. However, the ranking SVM still
shows a better performance in general. Changing the lin-
ear factors for the linear combinations to +3 for the main
target, −2 for the secondary target to be avoided with
higher priority, and−1 for the remaining secondary target
did not show any significant improvement in performance
for SVM LC.
Dual-target activity
The results of the experiments with the dual-target activ-
ity profiles are depicted in Figure 14 for the binary test
sets and in Figure 15 for the elaborated labeling described
in Table 2. Once again, the results are in line with
the aforementioned findings. The multi-target ranking
method generally shows a better performance except for
CYP2C19_CYP2D6 with a binary labeling of the test sets.
Regarding the experiments with the dehydrogenases data
set, the SVM with linear combinations features a lower
performance compared to MT RANK. This behavior may
Figure 8 Performance of the cytochrome P450 and dehydrogenase single-target data sets with binary test sets. Each boxplot depicts the
mean ranking error on the 20 randomly generated test sets for each target. The given ranking error is equal to 1 − AUC.
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Figure 9 Performance of the cytochrome P450 and dehydrogenase single-target data sets with ranking test sets. Each boxplot depicts the
mean ranking error on the 20 randomly generated test sets for each target.
derive from the fact that the SVM with linear combina-
tions has more problems when there are few compounds
for the desired label, since the multi-target ranking can
compensate this issue with the training instances of simi-
lar activity profiles. Approaches that are based on individ-
ual models train independent models for each respective
activity profile. MT RANK uses all activity profiles to
learn a model in one step and therefore is less prone to
fewer training instances, since activity profiles deviating
from the main target still contain information about their
targets. Another reason can be the imbalance between
dual-target training instances and training instance for
the respective undesired 3rd target, which does not seem
to be a problem for the multi-target ranking method.
The results for the non-binary labeling also show a lower
ranking error for MT RANK compared to SVM LC and
MC-SVM as could be observed in the results of the single-
target data sets.
Figure 10 Performance of the cytochrome P450s single-target data set with binary test sets. Each boxplot depicts the mean ranking error on
the 20 randomly generated test sets for each target separated according to the secondary target that should be avoided with higher priority. The
given ranking error is equal to 1 − AUC.
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Figure 11 Performance of the dehydrogenases single-target data set with binary test sets. Each boxplot depicts the mean ranking error on
the 20 randomly generated test sets for each target separated according to the secondary target that should be avoided with higher priority. The
given ranking error is equal to 1 − AUC.
Dual-target activity with different importance of the main
targets.
The Figures 16, 17, 18 and 19 show the results of the
same experiments with the dual-target activity profiles but
with the alternative labeling from Table 4. In this experi-
ment single-target activity profiles for the first of the two
main targets were regarded as more important than activ-
ity profiles for the second one. The results of both the
binary and the ranking test set show, that the ranking
scheme of Table 4 is less optimal for MT RANK and MC-
SVM than the one described in Table 2. When screen-
ing for a dual-target activity, a different prioritization of
Figure 12 Performance of the cytochrome P450s single-target data set with ranking test sets. Each boxplot depicts the mean ranking error
on the 20 randomly generated test sets for each target separated according to the secondary target that should be avoided with higher priority.
Dörr et al. Journal of Cheminformatics  (2015) 7:2 Page 13 of 18
Figure 13 Performance of the dehydrogenases single-target data set with ranking test sets. Each boxplot depicts the mean ranking error on
the 20 randomly generated test sets for each target separated according to the secondary target that should be avoided with higher priority.
both main targets seems to be more challenging for the
ranking SVM.
Trypsin-like protease data set
The chosen cutoffs 5.6, 6.1, and 6.6 combined with the
labeling of Table 3 resulted in the different distributions
of labels that are shown in Table 5. An increasing activity
cutoff results in more selective compounds for FXa and
fewer compounds that also target one of the secondary
targets. Figure 20 shows the performance on the
trypsin-like protease data set with the three differ-
ent selectivity cutoffs. Despite of the selected activity
cutoff, the linear ranking SVM has a lower ranking
error than SVM LC and MC-SVM. However, with a
decrease in compounds that are also selective for one
of the secondary targets the advantage of MT RANK
slowly diminishes. This behavior simply derives from
the fact, that there are less and less ranking errors to
be made.
Figure 14 Performance of the cytochrome P450 and dehydrogenase dual-target data sets with binary test sets. Each boxplot depicts the
mean ranking error on the 20 randomly generated test sets for each target. The given ranking error is equal to 1 − AUC.
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Figure 15 Performance of the cytochrome P450 and dehydrogenase dual-target data sets with ranking test sets. Each boxplot depicts the
mean ranking error on the 20 randomly generated test sets for each target.
Influence of the importance of different activity profiles
The results of the experiments with single and dual-
target activity indicate that the SVM with linear com-
binations has plainly more problems ranking similar
activity profiles higher than mere decoys. However, this
fact is not unexpected, since the SVM LC does not
optimize the ranking error during training. In addi-
tion, the MC-SVM with its distinct classes shows also a
higher ranking error compared to themulti-target ranking
approach. This issue is supported by examining the rank-
ing error (results not shown) among the active com-
pounds only and ignoring all decoys completely. SVM
LC and MC-SVM have more difficulties to rank com-
pounds similar to the main activity profile higher than
decoys. Furthermore, experiments show that increasing
the difference in importance between the active com-
pounds accounts for a decrease in the ranking error. In
this setup, the k-partite ranking error enforces a more
Figure 16 Performance of the cytochrome P450s dual-target data set with binary test sets. Each boxplot depicts the mean ranking error on
the 20 randomly generated test sets for each target separated according to which of both main target should be regarded with higher priority. The
given ranking error is equal to 1 − AUC.
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Figure 17 Performance of the dehydrogenases dual-target data set with binary test sets. Each boxplot depicts the mean ranking error on the
20 randomly generated test sets for each target separated according to which of both main target should be regarded with higher priority. The
given ranking error is equal to 1 − AUC.
strict ordering of active compounds with similar activity
profiles.
A comparison between additional ranking experiments
(results not shown) led us to the conclusion that treat-
ing completely non-selective compounds as decoys with
a label of 0 can in general be considered beneficial
for the ranking SVM. Especially, when their activity
can be related to non-specific events like protein bind-
ing or aggregation, non-selective compounds should not
be more important than decoys. However, the lower
Figure 18 Performance of the cytochrome P450s dual-target data set with ranking test sets. Each boxplot depicts the mean ranking error on
the 20 randomly generated test sets for each target separated according to which of both main target should be regarded with higher priority.
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Figure 19 Performance of the dehydrogenases dual-target data set with ranking test sets. Each boxplot depicts the mean ranking error on
the 20 randomly generated test sets for each target separated according to which of both main target should be regarded with higher priority.
performance of the binary classification of HADH2 in
Figure 11 indicates that in some cases valuable informa-
tion can even be contained in non-selective compounds if
their activity is not related to non-specific events. Remov-
ing non-selective compounds entirely from the training
set instead of keeping them as decoys did not influence
the performance significantly.
Difference between ECFPs and FCFPs
The results of the experiments with FCFPs show that
the performance of MT Rank and MC-SVM on the
cytochrome P450s data set is quite similar. In general,
the ECFP works slightly better with both methods. How-
ever, SVM LC shows a slightly better performance for the
targets CYP2C19_CYP3A4 and CYP2D6_CYP3A4. The
ranking error of SVM LC was significantly higher for
CYP2C19 and significantly lower for CYP2D6. Regard-
ing the dehydrogenases data set, it is noticeable that the
Table 5 Distribution of labels in the trypsin-like protease
data set for different activity cutoffs
Percentage of compounds with label
Cutoff 3 2 1 0
5.6 15 25 5 55
6.1 25 23 4 48
6.6 32 17 3 48
In this overview avoiding Thr is more important than Try. In the reverse case the
values for the labels 2 and 1 just have to be switched. The activity cutoff is given
in pKi .
FCFP shows a significantly higher ranking error for each
method. Nevertheless, the overall ratio in performance
between the methods did not depend on the choice of the
fingerprint.
Conclusions
To conclude, we think that the proposed encoding in com-
bination with SVMRank is able to handle compounds of
different activity profiles in a way that compounds not fit-
ting the desired activity profile to 100% are still part of the
higher scoring compounds in vHTS. Thus, each activity
profile can still be included in a virtual screening model
without losing information that is characteristic for each
specific activity profile. Especially, when already perfectly
matching ligands for a certain activity profile are not to
be expected in sufficient numbers in a vHTS, a medicinal
chemist can amend suboptimal compounds to suit certain
requirements. Therefore, a ranking SVM can be consid-
ered a valuable approach in multi-target vHTS because it
directly solves the actual problem in form of a small rank-
ing error for a specified problem instead of the ranking
derived from a classification model. The specific problem
encoded in the labeling of each data set is not fixed but
highly variable. The user can choose the labeling that fits
him best for his problem. To this extent, different criteria
can influence the labeling and the same activity profiles
can be treated differently depending on the task at hand.
But even if a more diverse composition of the upper ranks
of a virtual screening is not desired, our approach is still
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Figure 20 Performance of the trypsin-like protease data set with FXa as main target. Each boxplot depicts the mean ranking error on the 20
randomly generated test sets for each target separated according to the selected activity cutoff and which of the secondary targets should avoided
with higher priority.
feasible for a simple virtual screening as can be seen from
the experiments with the binary test sets.
In comparison to other methods, the ranking perfor-
mance is also robust against the chosen activity cutoff,
as demonstrated with the trypsin-like protease data set,
as long as there are enough compounds with different
ranking scores in the data set. Nevertheless, similarity-
based virtual screening methods are only as good as
the data set they are applied to. They can assist in the
drug design process and can speed up lead identifica-
tion, but their prospective results still have to be validated
experimentally since they strongly rely on the applicabil-
ity domain (AD) of the respective data set. Therefore, it
is quite difficult to examine a different AD and a diver-
gent region of the chemical space other than the one the
data set was provided for. If the compounds of a data set
are structurally too similar, the finding of entirely differ-
ent scaffolds for the same binding pocket is not to be
expected.
A focus in future studies might be to redesign this
method to focus on a single main target and include selec-
tivity information of secondary targets in form of different
pKi values. Therefore, lead candidates for a specific target
can be identified that also have a desired selectivity profile
against a number of secondary targets. It is possible that
the activity against a desired target is caused not by the
target itself but rather by an activity at another downsteam
or upstream location. This can be a problem for all multi-
target methods and has to be assessed in further studies.
The exclusion of compounds for some assays regarding
this problem could be beneficial for the performance of
multi-target methods. Furthermore, the methodology of
transductive SVMs [41] could be used to enable training
on data sets with missing labels. The principles shown in
this paper could be used in future studies to calculate the
importance of a feature for the activity against a specific
target.
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